Atlas Trials

Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis, Living With or Without HIV

Clinical trial NCT02906007 · COMPLETED

Trial details

NCT number
NCT02906007
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
TuberculosisHIV
Start date
2017-09-21
Primary completion
2024-02-07
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.